New Dietary Recommendation for Managing Gastrointestinal Issues Treated with GLP-1 Receptor Agonists

Published On 2025-02-01 11:21 GMT   |   Update On 2025-02-01 12:05 GMT

A recent commentary article published in Diabetes, Metabolic Syndrome and Obesity provides dietary recommendations for individuals using GLP-1 receptor agonists (GLP-1RAs), such as Ozempic, prescribed for obesity and type 2 diabetes. The study emphasizes optimizing meal composition to improve patient adherence to treatment.

While these drugs are effective for weight management, they can cause gastrointestinal side effects like nausea, diarrhea, and constipation due to delayed gastric emptying. The research paper led by Silvia Gentinetta et.al. emphasizes the importance of dietary choices in managing these side effects and improving patient adherence to treatment.

GLP-1RAs influence hunger and satiety, reducing energy intake and promoting weight loss. These medications also slow down gastric emptying, which leads to gastrointestinal issues.

The article highlights the need for specific dietary recommendations to manage these symptoms, particularly in the evening, when they tend to be more pronounced.

Key Dietary Recommendations from the published paper include:

  • Macronutrient Balance: Meals should include all three macronutrients (carbohydrates, proteins, and fats) while paying attention to their effects on gastric emptying.
  • Carbohydrates: Focus on complex carbohydrates like pasta, bread, and crackers in moderation, while limiting whole grains and simple sugars.
  • Proteins: Choose low-fat protein sources such as white meats, fish and fresh cheeses and avoid red meats, processed meats, and mature cheeses.
  • Fats: Use extra virgin olive oil in moderation, due to its health benefits, but be aware that fats can slow down gastric emptying.
  • Vegetables: Include low-fiber vegetables in appropriate portion sizes, avoiding those with peels and seeds.
  • Fiber: Limit high-fiber foods, especially in the evening, because they can slow gastric emptying.
  • Cooking Methods: Use simple methods like steaming, baking, or boiling, and avoid complex dishes, spicy foods, and alcohol.
  • Hydration: Stay hydrated by drinking water in small sips and avoid excessive intake during meals.
  • Meal Timing: Have small, frequent meals, and avoid lying down or engaging in vigorous activity after meals. It is recommended to eat slowly.
  • Foods to Avoid: Avoid consuming liquid foods like soups during the evening meal. (Refer Figure 1)

Figure 1: The dinner of the patient treated with GLP-1 receptor agonist.

Additionally, the authors have put forth behavioral recommendations for managing meals effectively (Refer Figure 2)


Figure 2: Behavioral Recommendations For Managing Meals

The authors emphasize that these dietary recommendations, developed based on a review of existing literature and dietary guidelines, can improve patient adherence to treatment while preventing therapy discontinuation. However, further research is needed to explore how food properties and lifestyle factors influence gastric emptying and to develop even more targeted dietary management strategies.

These recommendations contribute valuable insights for clinicians and patients, offering practical guidance on managing gastrointestinal side effects while using GLP-1RAs. As the scientific interest in GLP-1RA-mediated gastric emptying delays continues to grow, tailored dietary interventions could enhance obesity management and improve patient outcomes.

Reference: Gentinetta S, Sottotetti F, Manuelli M, Cena H. Dietary Recommendations for the Management of Gastrointestinal Symptoms in Patients Treated with GLP-1 Receptor Agonist. Diabetes Metab Syndr Obes. 2024 Dec 19;17:4817-4824. doi: 10.2147/DMSO.S494919. PMID: 39722834; PMCID: PMC11668918.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News